Does Combination Therapy With SGLT2 Inhibitors and Renin-Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
作者信息
Zhao Li-Min, Zhang Miao, Zhan Ze-Lin, Qiu Mei
机构信息
Department of Endocrinology, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Department of Nephrology, Shenzhen Hospital of Beijing University of Chinese Medicine, Shenzhen, China.
出版信息
Front Cardiovasc Med. 2021 May 5;8:679124. doi: 10.3389/fcvm.2021.679124. eCollection 2021.
Abstract
摘要
Zotero 插件